抗菌药物对铜绿假单胞菌、木糖氧化无色杆菌和嗜麦芽窄食单胞菌角膜炎分离株的活性比较
该研究比较了12种抗菌药物对来自角膜炎临床病例的58株铜绿假单胞菌、木糖氧化无色杆菌和嗜麦芽窄食单胞菌角膜分离株的体外最低抑菌浓度。木糖氧化无色杆菌和嗜麦芽窄食单胞菌对氟喹诺酮类、氨基糖苷类和头孢他啶的敏感率为0%至30%,而铜绿假单胞菌对这些药物的敏感率为95%至100%(P<0.00001)。米诺环素和甲氧苄啶/磺胺甲噁唑对木糖氧化无色杆菌和嗜麦芽窄食单胞菌的敏感率为90%至100%。
要点
- 木糖氧化无色杆菌和嗜麦芽窄食单胞菌对氟喹诺酮类、氨基糖苷类和头孢他啶的敏感率为0%至30%,铜绿假单胞菌为95%至100%(P<0.00001)。
- 莫西沙星对嗜麦芽窄食单胞菌的敏感率为80%,Cmax/MIC=10.19。
- 米诺环素和甲氧苄啶/磺胺甲噁唑对木糖氧化无色杆菌和嗜麦芽窄食单胞菌的敏感率为90%至100%。
核心结论
- 木糖氧化无色杆菌、嗜麦芽窄食单胞菌和铜绿假单胞菌之间的药敏模式存在显著差异。
- 氟喹诺酮类和氨基糖苷类可能对木糖氧化无色杆菌和嗜麦芽窄食单胞菌无效。
- 作者认为应考虑使用非滴眼液商业剂型的抗生素,如针对木糖氧化无色杆菌的β-内酰胺类,以及针对木糖氧化无色杆菌和嗜麦芽窄食单胞菌的甲氧苄啶/磺胺甲噁唑和米诺环素。
研究设计与样本
- 从Bascom Palmer眼科研究所微生物数据库提取58株角膜分离株,采用E-test法记录氟喹诺酮类、氨基糖苷类、β-内酰胺类及其他抗生素的体外最低抑菌浓度药敏谱,并计算药效学指标Cmax/MIC。
主要发现
- 木糖氧化无色杆菌和嗜麦芽窄食单胞菌对氟喹诺酮类、氨基糖苷类和头孢他啶的敏感率为0%至30%,铜绿假单胞菌对这些药物的敏感率为95%至100%(各药物P<0.00001)。
- 莫西沙星对嗜麦芽窄食单胞菌的敏感率为80%,Cmax/MIC=10.19。
- 米诺环素和甲氧苄啶/磺胺甲噁唑对木糖氧化无色杆菌和嗜麦芽窄食单胞菌的敏感率均为90%至100%。
- 100%的木糖氧化无色杆菌分离株对哌拉西林/他唑巴坦和替卡西林/克拉维酸敏感。
临床怎么用
- 作者认为氟喹诺酮类和氨基糖苷类可能对木糖氧化无色杆菌和嗜麦芽窄食单胞菌无效。
- 作者认为应考虑使用非滴眼液商业剂型的抗生素,如针对木糖氧化无色杆菌的β-内酰胺类,以及针对木糖氧化无色杆菌和嗜麦芽窄食单胞菌的甲氧苄啶/磺胺甲噁唑和米诺环素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: Achromobacter xylosoxidans and Stenotrophomonas maltophilia are emerging corneal pathogens, which are closely related to Pseudomonas aeruginosa, and have intrinsic resistance to many commonly available antimicrobials. The purpose of this study is to compare the in vitro efficacy of 12 antimicrobial agents against A. xylosoxidans, S. maltophilia and P. aeruginosa isolates recovered from clinical cases of keratitis. METHODS: Recovered corneal isolates (n=58) were identified and extracted from the Microbiology Data Bank of the Bascom Palmer Eye Institute. Comparative in vitro minimum inhibitory concentration (MIC) susceptibility profiles for fluoroquinolones, aminoglycosides, beta-lactams and miscellaneous antibiotics were recorded using the E-test methodology. Pharmacodynamic indices (Cmax/MIC) were calculated. RESULTS: A. xylosoxidans and S. maltophilia isolates were resistant to fluoroquinolones, aminoglycosides and ceftazidime (susceptibility rate ranging from 0% to 30%) while P. aeruginosa isolates showed a susceptibility rate of 95%-100% to these antimicrobials (P<0.00001 for the various antimicrobials). Exception was moxifloxacin with 80% of susceptibility rate to S. maltophilia isolates and Cmax/MIC=10.19. Ninety to 100% susceptibility rates were found for minocycline and trimethoprim/sulfamethoxazole for both A. xylosoxidans and S. maltophilia. One hundred per cent of the A. xylosoxidans isolates were susceptible to piperacillin/tazobactam and ticarcillin/clavulanic acid. CONCLUSIONS: There is a significant difference in susceptibility patterns between A. xylosoxidans, S. maltophilia and P. aeruginosa. Fluoroquinolones and aminoglycosides may not be effective against A. xylosoxidans and S. maltophilia. Antibiotics that are not commercially available as eye drops, such as beta-lactams for A. xylosoxidans, and trimethoprim/sulfamethoxazole and minocycline for both A. xylosoxidans and S. maltophilia should be considered.
引用
- Spierer O, Miller D, O'Brien TP, et al. Comparative activity of antimicrobials against Pseudomonas aeruginosa, Achromobacter xylosoxidans and Stenotrophomonas maltophilia keratitis isolates. Br J Ophthalmol. 2018. PMID: 29459431. doi:10.1136/bjophthalmol-2017-311751
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。